+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antacids Global Market Report 2022, By Drug Class, Distribution Channel, Formulation Type

  • PDF Icon

    Report

  • 175 Pages
  • March 2022
  • Region: Global
  • The Business Research Company
  • ID: 5559814
Antacids Global Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the global antacids market as it emerges from the Covid 19 shut down.



Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for the antacids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antacids Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope


Markets Covered:
1) Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
2) Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Others
3) By Formulation Type: Tablet; Liquid; Powder; Others

Companies Mentioned: GlaxoSmithKline plc.; Pfizer Inc.; Bayer AG; Dr. Reddy's Laboratories Ltd.; AstraZeneca PLC.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Antacids Market

What is the estimated value of the Global Antacids Market?

The Global Antacids Market was estimated to be valued at $9.13 billion in 2022.

What is the growth rate of the Global Antacids Market?

The growth rate of the Global Antacids Market is 4.4%, with an estimated value of $10.84 billion by 2026.

What is the forecasted size of the Global Antacids Market?

The Global Antacids Market is estimated to be worth $10.84 billion by 2026.

Who are the key companies in the Global Antacids Market?

Key companies in the Global Antacids Market include GlaxoSmithKline plc., Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd., AstraZeneca PLC., Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd., Takeda Pharmaceutical Company Limited and WellSpring Pharm.

Table of Contents

1. Executive Summary2. Antacids Market Characteristics3. Antacids Market Trends And Strategies4. Impact Of COVID-19 On Antacids
5. Antacids Market Size And Growth
5.1. Global Antacids Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Antacids Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Antacids Market Segmentation
6.1. Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-Motility Agents
6.2. Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
6.3. Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Tablet
  • Liquid
  • Powder
  • Others

7. Antacids Market Regional And Country Analysis
7.1. Global Antacids Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Antacids Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Antacids Market
8.1. Asia-Pacific Antacids Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Antacids Market
9.1. China Antacids Market Overview
9.2. China Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Antacids Market
10.1. India Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Antacids Market
11.1. Japan Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Antacids Market
12.1. Australia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Antacids Market
13.1. Indonesia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Antacids Market
14.1. South Korea Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Antacids Market
15.1. Western Europe Antacids Market Overview
15.2. Western Europe Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Antacids Market
16.1. UK Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Antacids Market
17.1. Germany Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Antacids Market
18.4. France Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Antacids Market
19.1. Eastern Europe Antacids Market Overview
19.2. Eastern Europe Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Antacids Market
20.1. Russia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Antacids Market
21.1. North America Antacids Market Overview
21.2. North America Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Antacids Market
22.1. USA Antacids Market Overview
22.2. USA Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Antacids Market
23.1. South America Antacids Market Overview
23.2. South America Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Antacids Market
24.1. Brazil Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Antacids Market
25.1. Middle East Antacids Market Overview
25.2. Middle East Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Antacids Market
26.1. Africa Antacids Market Overview
26.2. Africa Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Antacids Market Competitive Landscape And Company Profiles
27.1. Antacids Market Competitive Landscape
27.2. Antacids Market Company Profiles
27.2.1. GlaxoSmithKline plc
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Pfizer Inc
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Bayer AG
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Dr. Reddy's Laboratories Ltd
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. AstraZeneca PLC
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Antacids Pipeline Analysis29. Key Mergers And Acquisitions In The Antacids Market30. Antacids Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer

Executive Summary

Major players in the antacids market are GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd and AstraZeneca PLC., Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd, Takeda Pharmaceutical Company Limited, Abbott Laboratories and WellSpring Pharm.

The global antacids market is expected to grow from $8.60 billion in 2021 to $9.13 billion in 2022 at a compound annual growth rate (CAGR) of 6.1%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $10.84 billion in 2026 at a CAGR of 4.4%.

The antacids market consists of sales of antacids which are used to neutralize stomach acid, and treat acid reflux, heartburn and indigestion. It includes drug class such as proton pump inhibitors, H2 antagonist, surgical simulators and acid neutralizers in the form of either tablet, liquid or powder. Examples of antacids include Alka Seltzer, Maalox, Mylanta, Rolaids, Tums and Pepto-Bismol.

The main classes of antacids are proton pump inhibitors, h2 antagonist, acid neutralizers and pro-motility agents. Proton-pump inhibitors are a type of drug that reduces stomach acid production significantly and for a long time. They accomplish so by blocking the H+/K+ ATPase proton pump in the stomach in an irreversible manner. The different types of formulations include tablet, liquid, powder, others and is distributed through various channels such as hospital pharmacies, retail pharmacies, others.

North America was the largest region in the antacids market in 2021. Middle East is expected to be the fastest growing region. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Poor lifestyle choices resulting in higher prevalence of acidity is an important driver for the growth of the antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of sleep and irregular dietary habits, which result in an increase in acidity level of the stomach and lead to gastroesophageal reflux disease. According to the American College of Gastroenterology, around 60 million Americans suffers from gastroesophageal reflux disease. This drives the demand for antacids.

The side effects related to antacids is a major restraint for the antacids market. Some of the common side effects of antacids include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may also cause side effects such as constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. In addition, antacids when consumed with other acidic drugs might lead to absorption of both the drugs resulting in reduced efficiency of both the drugs.

Mouth-melting antacid is an emerging trend in the antacid market. Antacids were available in tablet, liquid and powder form until now, however, researchers have now come up with mouth-melting antacids which are made up of micro mouth melting granules that easily melt in the mouth. These granules present in the antacids act in the form of effervescent. An example of a mouth melting instant relief antacid is Sunpharma's 'Pepmelt', which integrates the effects of herbal constituents present in it with the contemporary mouth melting technology.

The manufacturers of antacids in the USA need to comply with CFR - Code of Federal Regulations Title 21 laid down by the FDA. According to these regulations, an over-the-counter (OTC) antacid product in a form suitable for oral administration is recognized safe and effective only if it meets the conditions related to active ingredients established by the regulatory body.

The countries covered in the antacids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd.
  • AstraZeneca PLC.
  • Boehringer Ingelheim GmbH
  • Sun Pharmaceuticals Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Abbott Laboratories
  • WellSpring Pharm
  • Private Lable
  • GSK
  • Johnson & Johnson
  • Novartis Consurmer Health
  • CONBA
  • Xiuzheng Pharma
  • Sanofi
  • Bausch Health
  • CR SANJIU
  • Reckitt Benckiser Group plc.
  • Procter & Gamble
  • WalmartEquate
  • Chattem
  • Thornton and Ross Ltd.
  • McNeil Consumer Pharmaceuticals

Methodology

Loading
LOADING...